BOOSTRIX Polio susp inj (n ser pré) ser pré 0.5 ml
7680006810037
Pharmacode 1108220
CH-681
J07CA02
08.08.
Active substances:
1 / 3
google
Details
- GTIN
- 7680006810037
- Pharmacode
- 1108220
- Product number
- 0068101
- CPT
- -
- Packaging group
- 1
- Unit
- Fertigspritze(n)
- Composition
- toxoidum diphtheriae ≥ 2 U.I., toxoidum tetani ≥ 20 U.I., toxoidum pertussis 8 µg, haemagglutininum filamentosum von Bordetella pertussis 8 µg, pertactinum von Bordetella pertussis 2.5 µg, virus poliomyelitis typus 1 inactivatus 40 U., virus poliomyelitis typus 2 inactivatus 8 U., virus poliomyelitis typus 3 inactivatus 32 U., natrii chloridum corresp. natrium 1.8 mg, aluminium 0.5 mg ut aluminii hydroxidum hydricum ad adsorptionem et aluminii phosphas, medium 199, aqua ad iniectabile q.s. ad suspensionem pro 0.5 ml, residui: neomycini sulfas, polymyxini B sulfas, polysorbatum 80, formaldehydum.
Articles (1)
Boostrix Polio, Injektionssuspension
Injektionssuspension
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
toxoidum diphtheriae
|
- | Substance | Wirkstoff (Principe actif) |
|
toxoidum tetani
|
- | Substance | Wirkstoff (Principe actif) |
|
toxoidum pertussis
|
8.0 UG | Substance | Wirkstoff (Principe actif) |
|
haemagglutininum filamentosum
|
8.0 UG | Substance | Wirkstoff (Principe actif) |
|
pertactinum
|
2.5 UG | Substance | Wirkstoff (Principe actif) |
|
virus poliomyelitis typus 1 inactivatus
|
40.0 U | Substance | Wirkstoff (Principe actif) |
|
virus poliomyelitis typus 2 inactivatus
|
8.0 U | Substance | Wirkstoff (Principe actif) |
|
virus poliomyelitis typus 3 inactivatus
|
32.0 U | Substance | Wirkstoff (Principe actif) |
|
natrii chloridum
|
- | Substance | HNIDK |
|
natrium
|
1.8 MG | Substance | HBESI |
|
aluminium
|
0.5 MG | Substance | HBESI |
|
aluminii hydroxidum hydricum ad adsorptionem
|
- | Substance | HNIDK |
|
aluminii phosphas
|
- | Substance | HNIDK |
|
medium 199
|
- | Substance | HNIDK |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
|
neomycini sulfas
|
- | Substance | RESI |
|
polymyxini B sulfas
|
- | Substance | RESI |
|
polysorbatum 80
|
- | Substance | RESI |
|
formaldehydum
|
- | Substance | RESI |
Reimbursement information
Public price
CHF 41.30
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/09/2004
Authorization holder
GlaxoSmithKline AG
6340 Baar
Authorization information
- Swissmedic authorization number
- 681
- Drug name
- Boostrix Polio, Injektionssuspension
- Galenic form
- SUPA
- ATC Code
- J07CA02
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 01/04/2004
- Authorization expiration date
- 31/12/9999
- IT number
- 08.08.
- Domain
- Human medicine
Packaging details
- Description (FR)
- BOOSTRIX Polio susp inj (n ser pré) ser pré 0.5 ml
- Description (DE)
- BOOSTRIX Polio Inj Susp (n Fertspr) Fertspr 0.5 ml
- Market launch
- 01/04/2004
- Narcotic (BTM)
- No
Application methods
IMU